Q2 2024 · 13F-HR
RTW INVESTMENTS, LPholdings as filed
Filed 2024-08-14 · accession 0001493152-24-031911
$6.46B
Reported value
68
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $536.7M | 8.31% | 1,915,862 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $380.8M | 5.90% | 17,687,772 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $373.1M | 5.78% | 4,634,331 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $359.8M | 5.57% | 8,806,838 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $281.4M | 4.36% | 654,430 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $280.8M | 4.35% | 2,593,323 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $246.7M | 3.82% | 4,169,393 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $243.9M | 3.78% | 3,640,108 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $226.1M | 3.50% | 7,393,127 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $225.4M | 3.49% | 6,387,138 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $222.7M | 3.45% | 13,707,506 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $219.8M | 3.40% | 3,444,095 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $184.2M | 2.85% | 1,462,400 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $183.2M | 2.84% | 5,286,404 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $170.1M | 2.63% | 7,056,988 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $165.0M | 2.56% | 4,869,798 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $147.4M | 2.28% | 2,721,158 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $134.0M | 2.07% | 3,259,927 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $133.6M | 2.07% | 742,105 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $127.4M | 1.97% | 5,431,985 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $121.6M | 1.88% | 2,675,703 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $116.2M | 1.80% | 10,000,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $109.4M | 1.69% | 1,856,010 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $106.7M | 1.65% | 2,712,096 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $92.8M | 1.44% | 3,412,486 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $90.1M | 1.39% | 202,456 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $79.0M | 1.22% | 2,967,897 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $76.6M | 1.19% | 3,258,360 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $67.0M | 1.04% | 4,078,122 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $59.7M | 0.92% | 3,557,347 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $59.5M | 0.92% | 5,480,577 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $59.1M | 0.92% | 7,378,548 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $57.1M | 0.88% | 4,224,838 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $45.8M | 0.71% | 5,620,640 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $45.7M | 0.71% | 386,291 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $42.4M | 0.66% | 1,344,074 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $42.1M | 0.65% | 18,800,299 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $39.0M | 0.60% | 1,070,565 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $38.8M | 0.60% | 3,327,129 | Common | SOLE |
| 92346J108 | VCEL | VERICEL CORP | $36.8M | 0.57% | 801,397 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $36.2M | 0.56% | 5,845,956 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $18.4M | 0.28% | 1,052,630 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $17.3M | 0.27% | 666,667 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $15.4M | 0.24% | 1,454,273 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $14.9M | 0.23% | 863,389 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $14.0M | 0.22% | 400,000 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $13.9M | 0.22% | 1,852,711 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $12.1M | 0.19% | 2,298,662 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $10.2M | 0.16% | 1,133,787 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $9.8M | 0.15% | 502,856 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $9.5M | 0.15% | 741,656 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $7.9M | 0.12% | 605,816 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.5M | 0.12% | 742,500 | Common | SOLE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $5.4M | 0.08% | 1,400,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $5.1M | 0.08% | 4,567,717 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.9M | 0.08% | 125,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $4.3M | 0.07% | 978,310 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $4.3M | 0.07% | 3,256,102 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $4.1M | 0.06% | 350,000 | Common | SOLE |
| 02008G102 | — | ALLURION TECHNOLOGIES INC | $3.7M | 0.06% | 3,697,549 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $2.8M | 0.04% | 1,511,866 | Common | SOLE |
| 78397T202 | SABS | SAB BIOTHERAPEUTICS INC | $2.4M | 0.04% | 766,946 | Common | SOLE |
| 232109108 | CUTREUR | CUTERA INC | $2.0M | 0.03% | 1,331,776 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $1.7M | 0.03% | 500,000 | Common | SOLE |
| G31659108 | — | ARYA SCIENCES ACQU CORP IV | $1.5M | 0.02% | 127,970 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $1.5M | 0.02% | 1,200,002 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.3M | 0.02% | 1,053,688 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $21,245 | 0.00% | 350,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.